The objective of the Program is to improve health care in the United States by developing Scholars to be patient-centered outcomes research (PCOR) scientists skilled in research, leadership, and translation, using comparative effectiveness research (CER) methods. CER supports PCOR through generation of knowledge about alternative strategies to inform the choices of patients and their caregivers, health care professionals, and policymakers. The evidence to support clinical, organizational and policy decisions in health care lags far behind what is needed. The challenge is that while there is an immense need for this knowledge, we have too few investigators focused on PCOR and trained in the tools of CER who also have the skills to engage patients and the public as partners in the course of the research and to be effective in translating research into action. The proposed program will: [Aim 1] Develop scientists with the knowledge, skills, and ability to become independent PCOR investigators and generate practical knowledge poised for application; [Aim 2] Develop future leaders who have the ability to lead broadly inclusive multidisciplinary teams in studying topics likely to improve health care and participate in leading positive change in health care; [Aim 3] Develop knowledge translators by building Scholar capacity to engage stakeholders, including patients and their caregivers, communicate about their research from inception through dissemination to a broad range of individuals using an array of approaches, and promote the application of the findings in actual practice. The program has a didactic component, including coursework and experiential learning, and mentored research experience. Scholars are expected to develop and implement at least two major individual research projects; successful Scholars will receive a Masters in Health Services degree. Faculty represent an extraordinary breadth of disciplines from a wide array of schools within Yale, including Medicine, Nursing, Public Health, Law, Management, and Arts and Sciences, and areas within medicine, including internal medicine, pediatrics, emergency medicine, obstetrics and gynecology, and psychiatry. The program will be two to three years in duration, based upon Scholars' prior training. We anticipate recruiting three Scholars in the first year of implementation, increasing t four or five in subsequent years. Candidates must: a) have a Doctoral Degree (MD, DO or PhD, or equivalent) from an accredited program and b) be a United States citizen or non-citizen national, or be lawfully admitted for permanent residence. In addition to these minimal formal requirements, the following qualifications are essential: a) evidence of a strong commitment to PCOR and CER; b) a record of academic excellence in fields of previous academic or clinical training; c) a commitment to work with stakeholders as partners and to focus on knowledge generation and translation.

Public Health Relevance

Our goal is to accelerate progress toward a truly patient-centered, evidence-based, high-performing health care system by increasing the nation's capacity to pursue patient-centered outcomes research and comparative effectiveness research. These methods can provide important knowledge to inform the choices of patients and their caregivers, health care professionals, and policymakers. The challenge is that we have too few researchers with these skills. Therefore, we propose a career development program to prepare highly trained researchers to meet this national need.

National Institute of Health (NIH)
Agency for Healthcare Research and Quality (AHRQ)
Physician Scientist Award (Program) (PSA) (K12)
Project #
Application #
Study Section
Special Emphasis Panel (ZHS1)
Program Officer
Benjamin, Shelley
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Internal Medicine/Medicine
Schools of Medicine
New Haven
United States
Zip Code
Wilkinson, Samuel T; Kiselycznyk, Carly; Banasr, Mounira et al. (2018) Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression. J Affect Disord 241:514-518
Katz, R B; Toprak, M; Wilkinson, S T et al. (2018) Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor. Gen Hosp Psychiatry 54:62-64
Wang, Yun; Spatz, Erica S; Tariq, Maliha et al. (2017) Home Health Agency Performance in the United States: 2011-15. J Am Geriatr Soc 65:2572-2579
Spatz, Erica S; Krumholz, Harlan M; Moulton, Benjamin W (2017) Prime Time for Shared Decision Making. JAMA 317:1309-1310
Ross, Joseph S; Bates, Jonathan; Parzynski, Craig S et al. (2017) Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter-defibrillators. Med Devices (Auckl) 10:165-188
Bucholz, Emily M; Strait, Kelly M; Dreyer, Rachel P et al. (2017) Editor's Choice-Sex differences in young patients with acute myocardial infarction: A VIRGO study analysis. Eur Heart J Acute Cardiovasc Care 6:610-622
Huo, Xiqian; Spatz, Erica S; Ding, Qinglan et al. (2017) Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open 7:e018302
Dreyer, Rachel P; Sciria, Christopher; Spatz, Erica S et al. (2017) Young Women With Acute Myocardial Infarction: Current Perspectives. Circ Cardiovasc Qual Outcomes 10:
Shahu, Andi; Schwartz, Jennifer; Perez, Mallory et al. (2017) Discerning quality: an analysis of informed consent documents for common cardiovascular procedures. BMJ Qual Saf 26:569-571
Roy, Brita; Gottlieb, Amy S (2017) The Career Advising Program: A Strategy to Achieve Gender Equity in Academic Medicine. J Gen Intern Med 32:601-602

Showing the most recent 10 out of 40 publications